Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Based on the results of the acute dermal toxicity study as well as the read across in vitro eye irritation studies, the test substance, 'di-C18-22 AAEMIM-MS', is considered to be non-irritating to the skin and irritating to the eyes.

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records
Reference
Endpoint:
skin corrosion: in vitro / ex vivo
Data waiving:
study scientifically not necessary / other information available
Justification for data waiving:
the study does not need to be conducted because an acute toxicity study by the dermal route does not indicate skin irritation up to the relevant limit dose level (2 000 mg/kg body weight)
Reason / purpose for cross-reference:
data waiving: supporting information
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
July 05, 2018
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU method B.47 (Bovine corneal opacity and permeability test method for identifying ocular corrosives and severe irritants)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Species:
cattle
Strain:
not specified
Details on test animals or tissues and environmental conditions:
Source of Bovine Eyes
Eyes from adult cattle (typically 12 to 60 months old) were obtained from a local abattoir as a by-product from freshly slaughtered animals. The eyes were excised by an abattoir employee after slaughter, and were placed in Hanks’ Balanced Salt Solution (HBSS) supplemented with antibiotics (penicillin at 100 IU/mL and streptomycin at 100 µg/mL). They were transported to the test facility over ice packs on the same day of slaughter. The corneas were prepared immediately on arrival.
Vehicle:
physiological saline
Controls:
yes, concurrent positive control
yes, concurrent negative control
Amount / concentration applied:
0.75 mL test substance or reference substances (Positive control: 20% w/v imidazole solution in sodium chloride 0.9% w/v, Negative control: Sodium chloride 0.9% w/v)
Duration of treatment / exposure:
At 32 ± 1 ºC for 240 minutes
Duration of post- treatment incubation (in vitro):
At 32 ± 1 ºC for 90 minutes for permeablity assessment
Number of animals or in vitro replicates:
Three corneas to each test substance and reference substances
Details on study design:
Preparation of corneas
All eyes were macroscopically examined before and after dissection. Only corneas free of damage were used. The cornea from each selected eye was removed leaving a 2 to 3 mm rim of sclera to facilitate handling. The iris and lens were peeled away from the cornea. The isolated corneas were immersed in a dish containing HBSS until they were mounted in Bovine Corneal Opacity and Permeability (BCOP) holders. The anterior and posterior chambers of each BCOP holder were filled with complete Eagle’s Minimum Essential Medium (EMEM) without phenol red and plugged. The holders were incubated at 32 ± 1 ºC for 75 minutes. At the end of the incubation period each cornea was examined for defects. Only corneas free of damage were used.
 
Selection of corneas and opacity reading
The medium from both chambers of each holder was replaced with fresh complete EMEM. A pre-treatment opacity reading was taken for each cornea using a calibrated opacitometer.Three corneas were randomly allocated to the negative control. Three corneas were also allocated to the test substance and three corneas to the positive control substance.
 
Treatment of corneas
The EMEM was removed from the anterior chamber of the BCOP holder and 0.75 mL of the test substance preparation or control substances were applied to the appropriate corneas. The holders were gently tilted back and forth to ensure a uniform application of the substance over the entire cornea. Each holder was incubated, anterior chamber uppermost, at 32 ± 1 ºC for 240 minutes. At the end of the exposure period the test substance and control substances were removed from the anterior chamber and the cornea was rinsed three times with fresh complete EMEM containing phenol red before a final rinse with complete EMEM without phenol red. The anterior chamber was refilled with fresh complete EMEM without phenol red. A post-treatment opacity reading was taken and each cornea was visually observed.
 
Application of sodium fluorescein
Following the opacity measurement the permeability of the corneas to sodium fluorescein was evaluated. The medium from the anterior chamber was removed and replaced with 1 mL of sodium fluorescein solution (5 mg/mL). The dosing holes were plugged and the holders incubated, anterior chamber uppermost, at 32 ± 1 ºC for 90 minutes.
 
Permeability determinations
After incubation the medium in the posterior chamber of each holder was decanted and retained. 360 µL of media representing each cornea was dispensed into the appropriate wells of a pre-labeled 96-well plate. The optical density was measured (quantitative viability analysis) at 492 nm (without a reference filter) using the Labtech LT-4500 microplate reader.
 
Histopathology
The corneas were retained after testing for possible conduct of histopathology. Each cornea was placed into a pre-labeled tissue cassette fitted with a histology sponge to protect the endothelial surface. The cassette was immersed in 10% neutral buffered formalin. In this study histopathology was not required.
 
Data evaluation
Results from the two test method endpoints, opacity and permeability, were combined in an empirically derived formula to generate an In Vitro Irritancy Score.
 
Opacity measurement
The change in opacity for each cornea (including the negative control) was calculated by subtracting the initial opacity reading from the final opacity reading. These values were then corrected by subtracting the average change in opacity observed for the negative control corneas. The mean opacity value of each treatment group was then calculated by averaging the corrected opacity values of each cornea for that treatment group.
 
Permeability measurement
The corrected OD492 was calculated by subtracting the mean OD492 of the negative control corneas from the OD492 value of each treated cornea. The OD492 value of each treatment group was calculated by averaging the corrected OD492 values of the treated corneas for the treatment group.
 
In Vitro irritancy score
The following formula was used to determine the In Vitro Irritancy Score:
In Vitro Irritancy Score = mean opacity value + (15 x mean permeability OD492 value)
 
Additionally, the opacity and permeability values were evaluated independently to determine whether the test substance induced a response through only one of the two endpoints.
 
Visual observation
The condition of the cornea was visually assessed post treatment.
Irritation parameter:
in vitro irritation score
Run / experiment:
Test substance
Value:
ca. 0.7
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation parameter:
in vitro irritation score
Run / experiment:
Positive control
Value:
ca. 102.3
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Irritation parameter:
in vitro irritation score
Run / experiment:
Negative control
Value:
ca. 0.5
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
The positive control In Vitro Irritancy Score was within the range of 71.2 to 132.9. The positive control acceptance criterion was therefore satisfied. The negative control gave opacity of ≤2.3 and permeability ≤0.044. The negative control acceptance criteria were therefore satisfied.

Results

Corneal Opacity and Permeability measurement

Individual and mean corneal opacity measurements and individual and mean corneal permeability measurements are given in following table 1:

Treatment

Cornea Number

Opacity

Permeability (OD)

In Vitro Irritancy Score

Pre-Treatment

Post-Treatment

Post-Treatment- Pre‑Treatment

Corrected Value

 

Corrected Value

Negative Control

1

7

8

1

 

0.011

 

 

2

4

3

0

 

0.006

 

 

3

6

2

0

 

0.013

 

 

Average

 

 

0.3

 

0.010

 

0.5

Positive
Control

4

5

73

68

67.7

1.670

1.660

 

5

6

81

75

74.7

1.450

1.440

 

6

4

100

96

95.7

1.495

1.485

 

Average

 

 

 

79.3

 

1.528

102.3

Test Substance

7

4

5

1

0.7

0.053

0.043

 

9

6

7

1

0.7

0.010

0.000

 

10

6

5

-1

0.0

0.005

0.000

 

Average

 

 

 

0.4

 

0.014

0.7

OD= Optical density

 

Corneal Epithelium Condition

The condition of each cornea is given in below table:

Treatment

Cornea Number

Observation
Post Treatment

Negative Control

1

Clear

2

Clear

3

Clear

Positive Control

4

Cloudy

5

Cloudy

6

Cloudy

Test Substance

7

Clear

9

Clear

10

Clear

The corneas treated with the test substance were clear post treatment. The corneas treated with the negative control substance were clear post treatment. The corneas treated with the positive control substance were cloudy post treatment.

In Vitro Irritancy Score

The In Vitro irritancy scores are summarized as follows:

Treatment

In Vitro Irritancy Score

Test Substance

0.7

Negative Control

0.5

Positive Control

102.3

Criteria for an Acceptable Test

The positive control In Vitro Irritancy Score was within the range of 71.2 to 132.9. The positive control acceptance criterion was therefore satisfied. The negative control gave opacity of ≤2.3 and permeability ≤0.044. The negative control acceptance criteria were therefore satisfied.

Conclusion

No category. Not requiring classification to UN GHS or EU CLP.

Interpretation of results:
other: not classified based on EU CLP criteria
Conclusions:
Under the study conditions, the test substance was considered to be non-irritating to the eyes.


Executive summary:

An in vitro study was conducted to determine the eye irritation potential of the test substance, 'di- C18-22 AAEMIM-MS' (active: 101.3%), using Bovine corneal Opacity Test (BCOP), according to OECD Guideline 437 and EU Method B.47, in compliance with GLP. Eyes from adult cattle (typically 12 to 60 months old) were obtained from a local abattoir as a by-product from freshly slaughtered animals. Preparation, selection and opacity reading of the corneas were performed as per guideline. Prepared corneas in triplicates were treated with each, test substance (20% w/v in sodium chloride 0.9% w/v), negative control (Sodium chloride 0.9% w/v) and positive control (20% w/v Imidazole solution in sodium chloride 0.9% w/v) substances at 32 ± 1ºC for 240 minutes. At the end of the exposure period the test substance and control substances were removed from the anterior chamber and the cornea was rinsed three times with fresh complete Eagle’sMinimum Essential Medium (EMEM) containing phenol red before a final rinse with complete EMEM without phenol red. A post treatment opacity reading was taken and each cornea was visually observed. Following the opacity measurement the permeability of the corneas to sodium fluorescein was evaluated. The medium from the anterior chamber was removed and replaced with 1 mL of sodium fluorescein solution (5 mg/mL). The dosing holes were plugged and the holders incubated, anterior chamber uppermost, at 32 ± 1ºC for 90 minutes. The two endpoints, decreased light transmission through the cornea (opacity) and increased passage of sodium fluorescein dye through the cornea (permeability) were combined in an empirically derived formula to generate an In Vitro Irritancy Score (IVIS). The positive control group had an overall IVIS of 102.3, which was within the criteria range set for an acceptable test. The negative control gave opacity of ≤2.3 and permeability ≤0.044, the negative control acceptance criteria were therefore satisfied. The test substance IVIS score obtained was 0.7, which is well below the non-corrosive and corrosive limits of 3 and 55 respectively. Under the study conditions, the test substance was considered to be not requiring classification as per EU CLP (Envigo, 2018).

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Skin:

No additional testing was conducted, as the endpoint could be assessed based on the in vivo acute dermal study (discussed in the above section), which did not reveal any skin irritation reactions in rabbits up to the relevant limit dose level (2000 mg/kg bw) (MBRL, 2010).

Eye:

An in vitro study was conducted to determine the eye irritation potential of the test substance, 'di- C18-22 AAEMIM-MS' (active: 101.3%), using Bovine corneal Opacity Test (BCOP), according to OECD Guideline 437 and EU Method B.47, in compliance with GLP. Eyes from adult cattle (typically 12 to 60 months old) were obtained from a local abattoir as a by-product from freshly slaughtered animals. Preparation, selection and opacity reading of the corneas were performed as per guideline. Prepared corneas in triplicates were treated with each, test substance (20% w/v in sodium chloride 0.9% w/v), negative control (Sodium chloride 0.9% w/v) and positive control (20% w/v Imidazole solution in sodium chloride 0.9% w/v) substances at 32 ± 1ºC for 240 minutes. At the end of the exposure period the test substance and control substances were removed from the anterior chamber and the cornea was rinsed three times with fresh complete Eagle’sMinimum Essential Medium (EMEM) containing phenol red before a final rinse with complete EMEM without phenol red. A post treatment opacity reading was taken and each cornea was visually observed. Following the opacity measurement the permeability of the corneas to sodium fluorescein was evaluated. The medium from the anterior chamber was removed and replaced with 1 mL of sodium fluorescein solution (5 mg/mL). The dosing holes were plugged and the holders incubated, anterior chamber uppermost, at 32 ± 1ºC for 90 minutes. The two endpoints, decreased light transmission through the cornea (opacity) and increased passage of sodium fluorescein dye through the cornea (permeability) were combined in an empirically derived formula to generate an In Vitro Irritancy Score (IVIS). The positive control group had an overall IVIS of 102.3, which was within the criteria range set for an acceptable test. The negative control gave opacity of ≤2.3 and permeability ≤0.044, the negative control acceptance criteria were therefore satisfied. The test substance IVIS score obtained was 0.7, which is well below the non-corrosive and corrosive limits of 3 and 55 respectively. Under the study conditions, the test substance was considered to be not requiring classification as per EU CLP (Envigo, 2018).

Justification for classification or non-classification

Skin irritation:

Based on the results of the acute dermal toxicity study, the test substance, 'di-C18-22 AAEMIM-MS', does not warrant a skin irritation classification, according to the EU CLP criteria (Regulation 1272/2008/EC).

Eye irritation:

Based on the results of in vitro assay, the test substance, 'di-C18-22 AAEMIM-MS', does not warrant an eye irritation classification, according to the EU CLP criteria (Regulation 1272/2008/EC).